UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037315
Receipt No. R000042544
Scientific Title Efficacy of transcranial direct current stimulation (tDCS) on the treatment of neurological diseases
Date of disclosure of the study information 2019/07/09
Last modified on 2022/01/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Efficacy of transcranial direct current stimulation (tDCS) on the treatment of neurological diseases
Acronym Efficacy of transcranial direct current stimulation (tDCS) on the treatment of neurological diseases
Scientific Title Efficacy of transcranial direct current stimulation (tDCS) on the treatment of neurological diseases
Scientific Title:Acronym Efficacy of transcranial direct current stimulation (tDCS) on the treatment of neurological diseases
Region
Japan

Condition
Condition multiple sclerosis, NMOSD, Parkinsonism, brain infarction
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the efficacy of tDCS on the cognitive impairment, motor dysfunction, and dysphagia of neurological diseases
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Assessment of cognitive impairment before and after tDCS treatment
Key secondary outcomes Assessment of motor dysfunction before and after tDCS treatment

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 ten times tDCS during 2 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients in our hospital with multiple sclerosis, NMOSD, Parkinsonism, spinocerebellar degeneration, and brain infarction
Key exclusion criteria Patients with magnetic medical devices such as pace maker and brain aneurysm clip
Target sample size 16

Research contact person
Name of lead principal investigator
1st name Yuji
Middle name
Last name Nakatsuji
Organization Toyama University Hospital
Division name Department of Neurology
Zip code 930-0194
Address 2630 Sugitani, Toyama
TEL 076-434-7309
Email nakatsuj@med.u-toyama.ac.jp

Public contact
Name of contact person
1st name Hiroshi
Middle name
Last name Konishi
Organization Toyama University Hospital
Division name Department of Neurology
Zip code 930-0194
Address 2630 Sugitani, Toyama
TEL 076-434-7309
Homepage URL
Email koni16@med.u-toyama.ac.jp

Sponsor
Institute Toyama University Hospital
Institute
Department

Funding Source
Organization Ministry of Education
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Toyama University Hospital
Address 2630 Sugitani, Toyama
Tel 076-434-7309
Email nakatsuj@med.u-toyama.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 12 Month 01 Day
Date of IRB
2019 Year 01 Month 07 Day
Anticipated trial start date
2019 Year 03 Month 01 Day
Last follow-up date
2019 Year 07 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2021 Year 10 Month 18 Day

Other
Other related information

Management information
Registered date
2019 Year 07 Month 09 Day
Last modified on
2022 Year 01 Month 11 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042544